Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trials-Reference-Cited by-同舟云学术

Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trials

Published:2023-02-01 Issue:2 Volume:57 Page:140-151
ISSN:1071-5762
Container-title:Free Radical Research
language:en
Short-container-title:Free Radical Research

Author:

Larsen Emil List¹²,Andersen Andreas³⁴,Kjær Laura K.¹,Eickhoff Mie K.³,Frimodt-Møller Marie³,Persson Frederik³,Rossing Peter³⁵,Lykkesfeldt Jens⁶,Knop Filip K.³⁴⁵⁷,Vilsbøll Tina³⁴⁵,Rungby Jørgen⁴⁸⁹,Poulsen Henrik E.⁵⁸¹⁰

Affiliation:

1. Department of Clinical Pharmacology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark

2. Department of Clinical Biochemistry, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark

3. Steno Diabetes Center Copenhagen, Herlev, Denmark

4. Center for Clinical Metabolic Research, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark

5. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

6. Department of Veterinary and Animal Science, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark

7. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

8. Department of Endocrinology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark

9. Copenhagen Center for Translational Research, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark

10. Department of Cardiology, Copenhagen University Hospital – North Zealand, Hillerød, Denmark

Publisher

Informa UK Limited

Subject

General Medicine,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10715762.2023.2213820

Reference44 articles.

1. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications

2. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021

3. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021

4. How does diabetes accelerate Alzheimer disease pathology?

5. Diabetes and Cancer: A Consensus Report

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review;International Journal of Preventive Medicine;2024-06